{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:47:49Z","timestamp":1789789669524,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jpba.2024.116139","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T11:30:55Z","timestamp":1712575855000},"page":"116139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Target analysis of psychoactive drugs in oral fluid by QuEChERS extraction and LC-MS\/MS"],"prefix":"10.1016","volume":"244","author":[{"given":"Ettore Ferrari","family":"J\u00fanior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Souza","family":"Bitencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gatha Beatriz Mariano de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa Dutra","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116139_bib1","unstructured":"United Nations Office on Drugs and Crime - UNODC. World Drug Report 2023. \u3008https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2023.html\u3009 (Accessed 24 January, 2024)."},{"key":"10.1016\/j.jpba.2024.116139_bib2","unstructured":"European Monitoring Centre for Drugs and Drug Addiction - EMCDDA. European Drug Report 2023: Trends and Developments. \u3008https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2023_en\u3009. (Accessed 24 January, 2024)."},{"key":"10.1016\/j.jpba.2024.116139_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107889","article-title":"Trends in drug use among electronic dance music party attendees in New York City, 2016\u20132019","volume":"209","author":"Palamar","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jpba.2024.116139_bib4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11419-021-00600-y","article-title":"Determination of new psychoactive substances and other drugs in postmortem blood and urine by UHPLC\u2013MS\/MS: method validation and analysis of forensic samples","volume":"40","author":"Ferrari J\u00fanior","year":"2021","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jpba.2024.116139_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/jat\/bky051","article-title":"The detection of novel stimulants in oral fluid from users reporting ecstasy, molly and MDMA ingestion","volume":"42","author":"Krotulski","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116139_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FTD.0b013e3181ae46ea","article-title":"Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs","volume":"31","author":"Wille","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2024.116139_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jat\/bkaa104","article-title":"Evaluating trends in novel psychoactive substances using a sentinel population of electronic dance music festival attendees","volume":"45","author":"Mohr","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116139_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jat\/32.6.393","article-title":"Drug testing in oral fluid - evaluation of sample collection devices","volume":"32","author":"Langel","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116139_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jchromb.2017.09.003","article-title":"Determination of 74 new psychoactive substances in serum using automated in-line solid-phase extraction-liquid chromatography-tandem mass spectrometry","volume":"1064","author":"Lehmann","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2024.116139_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/dta.1657","article-title":"A simple extraction and LC-MS\/MS approach for the screening and identification of over 100 analytes in eight different matrices","volume":"7","author":"Montenarh","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116139_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123330","article-title":"Development of analytical method for the determination of methylphenidate, the analog ethylphenidate and their metabolite ritalinic acid in oral fluid samples by micro-QuEChERS and liquid chromatography\u2013tandem mass spectrometry","volume":"1205","author":"Chinaglia","year":"2022","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2024.116139_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.109936","article-title":"A new clean-up approach for stomach content toxicological analysis","volume":"302","author":"Peres","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116139_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/ftox.2022.1033733","article-title":"Fatal cases involving new psychoactive substances and trends in analytical techniques","volume":"4","author":"Ferrari J\u00fanior","year":"2022","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.jpba.2024.116139_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.forsciint.2012.11.006","article-title":"Recovery of spiked \u03949-tetrahydrocannabinol in oral fluid from polypropylene containers","volume":"227","author":"Molnar","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116139_bib15","unstructured":"ANSI\/ASB. Standard practices for method validation in forensic toxicology, 2019. \u3008https:\/\/www.aafs.org\/asb-standard\/standard-practices-method-validation-forensic-toxicology\u3009 (Accessed 22 November, 2022)."},{"key":"10.1016\/j.jpba.2024.116139_bib16","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/dta.2045","article-title":"Determination of 21 drugs in oral fluid using fully automated supported liquid extraction and UHPLC-MS\/MS","volume":"9","author":"Valen","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116139_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jat\/bkaa089","article-title":"Screening of 104 New psychoactive substances (NPS) and other drugs of abuse in oral fluid by LC-MS-MS","volume":"44","author":"da Cunha","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116139_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuropharm.2011.03.028","article-title":"High concentrations of MDMA ('ecstasy\u2019) and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells","volume":"61","author":"Hondebrink","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpba.2024.116139_bib19","article-title":"Eutylone Intoxications\u2014an emerging synthetic stimulant in forensic investigations","author":"Krotulski","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116139_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108962","article-title":"Prevalence of new psychoactive substances (NPS) in Brazil based on oral fluid analysis of samples collected at electronic music festivals and parties","volume":"227","author":"da Cunha","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jpba.2024.116139_bib21","article-title":"Analysis of non-derivatized 2-(4-R-2,5-dimethoxyphenyl)-N-[(2-hydroxyphenyl)methyl]ethanamine using short column gas chromatography - mass spectrometry.","volume":"1634","author":"Ferrari J\u00fanior","year":"2020","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116139_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpba.2016.11.040","article-title":"Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat u","volume":"134","author":"Caspar","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116139_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11419-022-00622-0","article-title":"High-sensitivity method for the determination of LSD and 2-oxo-3-hydroxy-LSD in oral fluid by liquid chromatography-tandem mass spectrometry","volume":"40","author":"da Cunha","year":"2022","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jpba.2024.116139_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/dta.1532","article-title":"Comparison of drug concentrations between whole blood and oral fluid","volume":"6","author":"Langel","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116139_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.forsciint.2018.01.006","article-title":"Is LSD toxic?","volume":"284","author":"Nichols","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2024.116139_bib26","first-page":"5","article-title":"Using biological samples in epidemiological research on drugs of abuse","volume":"21","author":"Gjerde","year":"2011","journal-title":"Nor. Epidemiol."},{"key":"10.1016\/j.jpba.2024.116139_bib27","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/add.13060","article-title":"Drug use in Australian nightlife settings: estimation of prevalence and validity of self-report","volume":"110","author":"Miller","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.jpba.2024.116139_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugpo.2017.07.010","article-title":"Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene","volume":"48","author":"Palamar","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.jpba.2024.116139_bib29","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1080\/10826084.2019.1580295","article-title":"Correspondence between Oral Fluid Drug Test Results and Self-reported Illicit Drug Use among Music Festival attendees","volume":"54","author":"Gjerde","year":"2019","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.jpba.2024.116139_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11419-018-0456-3","article-title":"Profile of new psychoactive substances (NPS) and other synthetic drugs in seized materials analysed in a Brazilian forensic laboratory","volume":"37","author":"Machado","year":"2019","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.jpba.2024.116139_bib31","unstructured":"United Nations Office on Drugs and Crime - UNODC. Current NPS threats, volume 6, 2023. \u3008https:\/\/www.unodc.org\/unodc\/en\/scientists\/current-nps-threats.html\u3009. (Accessed 10 January, 2024)."},{"key":"10.1016\/j.jpba.2024.116139_bib32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugpo.2016.12.021","article-title":"Motivations for new psychoactive substance use among regular psychostimulant users in Australia","volume":"43","author":"Sutherland","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.jpba.2024.116139_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.legalmed.2015.06.002","article-title":"Postmortem distribution of flunitrazepam and its metabolite 7-aminoflunitrazepam in body fluids and solid tissues in an autopsy case: usefulness of bile for their detection","volume":"17","author":"Hasegawa","year":"2015","journal-title":"Leg. Med."},{"key":"10.1016\/j.jpba.2024.116139_bib34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1556-4029.2012.02254.x","article-title":"A fatality following ingestion of the designer drug meta-chlorophenylpiperazine (mCPP) in an asthmatic-HPLC-MS\/MS detection in biofluids and hair","volume":"58","author":"Gaillard","year":"2013","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.jpba.2024.116139_bib35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11419-022-00646-6","article-title":"The mystery behind the apprehensions of the selective cannabinoid receptor type-2 agonist BZO-HEXOXIZID (MDA-19) as a drug of abuse","volume":"41","author":"de Araujo","year":"2023","journal-title":"Forensic Toxicol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T07:19:07Z","timestamp":1714029547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524001791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":35,"alternative-id":["S0731708524001791"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116139","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Target analysis of psychoactive drugs in oral fluid by QuEChERS extraction and LC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116139"}}